16:25 EDT MacroGenics (MGNX) trading halted, news pending
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MGNX:
- Is MGNX a Buy, Before Earnings?
- MacroGenics Expands ZYNYZ Royalty Agreement for Added Funding
- MacroGenics, Sagard enter expanded Zynyz royalty purchase agreement
- MacroGenics price target raised to $6 from $4 at Barclays
- MacroGenics Nears Key Prostate Cancer Catalyst as Phase 2 Lorigerlimab Trial Completes